A detailed history of Charles Schwab Investment Management Inc transactions in Johnson & Johnson stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 17,536,866 shares of JNJ stock, worth $2.9 Billion. This represents 0.49% of its overall portfolio holdings.

Number of Shares
17,536,866
Previous 16,177,932 8.4%
Holding current value
$2.9 Billion
Previous $2.56 Billion 0.16%
% of portfolio
0.49%
Previous 0.6%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$144.38 - $157.78 $196 Million - $214 Million
1,358,934 Added 8.4%
17,536,866 $2.56 Billion
Q1 2024

May 08, 2024

BUY
$155.22 - $162.74 $36.1 Million - $37.8 Million
232,399 Added 1.46%
16,177,932 $2.56 Billion
Q4 2023

Feb 06, 2024

BUY
$145.6 - $158.88 $35.2 Million - $38.4 Million
241,799 Added 1.54%
15,945,533 $2.5 Billion
Q3 2023

Nov 08, 2023

SELL
$155.75 - $174.48 $221 Million - $248 Million
-1,419,551 Reduced 8.29%
15,703,734 $2.45 Billion
Q2 2023

Aug 09, 2023

SELL
$154.35 - $166.11 $3.56 Million - $3.83 Million
-23,034 Reduced 0.13%
17,123,285 $2.83 Billion
Q1 2023

May 11, 2023

BUY
$151.05 - $180.26 $9.02 Million - $10.8 Million
59,748 Added 0.35%
17,146,319 $2.66 Billion
Q4 2022

Feb 13, 2023

BUY
$160.2 - $179.79 $28 Million - $31.4 Million
174,516 Added 1.03%
17,086,571 $3.02 Billion
Q3 2022

Nov 14, 2022

BUY
$161.33 - $179.52 $55.5 Million - $61.7 Million
343,752 Added 2.07%
16,912,055 $2.76 Billion
Q2 2022

Aug 15, 2022

SELL
$168.19 - $186.01 $104 Million - $115 Million
-620,926 Reduced 3.61%
16,568,303 $2.94 Billion
Q1 2022

May 13, 2022

BUY
$158.14 - $179.59 $51.9 Million - $59 Million
328,297 Added 1.95%
17,189,229 $3.05 Billion
Q4 2021

Feb 11, 2022

BUY
$155.93 - $173.01 $67.3 Million - $74.6 Million
431,394 Added 2.63%
16,860,932 $2.88 Billion
Q3 2021

Nov 16, 2021

BUY
$161.5 - $179.47 $28.4 Million - $31.6 Million
176,155 Added 1.08%
16,429,538 $2.65 Billion
Q2 2021

Aug 16, 2021

BUY
$159.48 - $171.07 $56.8 Million - $61 Million
356,306 Added 2.24%
16,253,383 $2.68 Billion
Q1 2021

May 17, 2021

BUY
$153.07 - $170.48 $34.1 Million - $37.9 Million
222,457 Added 1.42%
15,897,077 $2.61 Billion
Q4 2020

Feb 16, 2021

BUY
$137.11 - $157.38 $5.13 Million - $5.89 Million
37,447 Added 0.24%
15,674,620 $2.47 Billion
Q3 2020

Nov 13, 2020

SELL
$140.38 - $153.83 $111 Million - $121 Million
-787,490 Reduced 4.79%
15,637,173 $2.33 Billion
Q2 2020

Aug 14, 2020

SELL
$128.81 - $155.51 $18.8 Million - $22.7 Million
-145,704 Reduced 0.88%
16,424,663 $2.31 Billion
Q1 2020

May 15, 2020

BUY
$111.14 - $153.99 $469 Million - $650 Million
4,223,328 Added 34.21%
16,570,367 $2.17 Billion
Q4 2019

Feb 07, 2020

BUY
$127.5 - $146.44 $11.2 Million - $12.9 Million
88,125 Added 0.72%
12,347,039 $1.8 Billion
Q3 2019

Nov 08, 2019

SELL
$126.95 - $142.14 $17.9 Million - $20 Million
-140,906 Reduced 1.14%
12,258,914 $1.59 Billion
Q2 2019

Aug 09, 2019

BUY
$131.15 - $144.24 $27.5 Million - $30.2 Million
209,429 Added 1.72%
12,399,820 $1.73 Billion
Q1 2019

May 14, 2019

BUY
$125.72 - $139.79 $55.4 Million - $61.5 Million
440,300 Added 3.75%
12,190,391 $1.7 Billion
Q4 2018

Feb 14, 2019

BUY
$122.84 - $147.84 $24.1 Million - $29 Million
195,991 Added 1.7%
11,750,091 $1.52 Billion
Q3 2018

Nov 13, 2018

BUY
$121.58 - $142.88 $63.7 Million - $74.9 Million
523,937 Added 4.75%
11,554,100 $1.6 Billion
Q2 2018

Aug 08, 2018

BUY
$119.4 - $131.76 $45.9 Million - $50.6 Million
384,098 Added 3.61%
11,030,163 $1.34 Billion
Q1 2018

May 07, 2018

SELL
$125.1 - $148.14 $241 Million - $286 Million
-1,930,295 Reduced 15.35%
10,646,065 $1.36 Billion
Q4 2017

Jan 17, 2018

BUY
$131.22 - $143.62 $72.4 Million - $79.2 Million
551,632 Added 4.59%
12,576,360 $1.76 Billion
Q3 2017

Nov 13, 2017

BUY
$129.47 - $135.38 $1.56 Billion - $1.63 Billion
12,024,728
12,024,728 $1.56 Billion

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $433B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Charles Schwab Investment Management Inc Portfolio

Follow Charles Schwab Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.